Skip to McMaster Navigation Skip to Site Navigation Skip to main content

Pregnancy-related sleep changes linked to depression and anxiety

The findings indicate that stabilizing biological rhythms could lessen depressive symptoms at specific times and help prevent postpartum depression.

By Fram Dinshaw, Faculty of Health Sciences January 18, 2022

A pregnant woman lying down with her eyes closed.
Changes in sleep and biological rhythms from late pregnancy to the postpartum period are linked to depression and anxiety

Expert Featured In This Story

Benicio Frey
Benicio Frey

Professor

See Profile

Changes in sleep patterns during late pregnancy and shortly afterwards are closely related to severe depression and anxiety, a new McMaster-led study finds.

Senior author Benicio Frey said an estimated 15 to 18 per cent of mothers experience anxiety, and another 7 to 13 per cent have depression during the peripartum period.

As well, nearly 10 per cent of new mothers experience clinical levels of comorbid anxiety and depression during this time.

Researchers identified several variables linked to depression and anxiety, including changes in the strength of the circadian rhythms, the average amount of activity during night-time rest and fragmented sleep. All three were strongly linked to higher depressive and anxiety symptoms.

“Our findings highlight the importance of stabilizing the internal biological clock during the peripartum period to maintain healthy mood and minimize anxiety,” said Frey, a professor in the department of psychiatry and behavioural neurosciences in the Faculty of Health Sciences.

“Given the findings, future efforts should be made to standardize evidence-based interventions targeting these biological rhythms variables identified by our team, either as treatment or prevention strategies.”

Frey and his research team conducted their study at the Women’s Health Concerns Clinic at St. Joseph’s Healthcare Hamilton. This clinic specializes in psychiatric disorders during the peripartum, premenstrual, and perimenopausal periods.

Researchers recruited 100 women, 73 of whom they followed from the start of the third trimester to three months postpartum. They analyzed subjective and objective measures of sleep, biological rhythms, melatonin levels, and light exposure using a variety of tools, including questionnaires, actigraphs (wearable sleep monitors), laboratory assays, and other methods.

Frey said the findings indicate that certain biological rhythms variables may influence depressive symptoms at specific points along the peripartum timeline.

For example, higher fragmentation of nighttime rest was linked to a decrease in depressive symptoms at six to 12 weeks postpartum, a period that tends to coincide with a higher risk of developing postpartum depression, which suggests that mothers with fewer symptoms of depression were more responsive to the overnight baby’s needs.

The comprehensive findings were published in the Journal of Clinical Psychiatry on Jan. 18. The study was the largest to date investigating sleep and biological rhythms during the peripartum period.

Support for the study was provided in part by the Research Institute of St. Joe’s Hamilton and the Teresa Cascioli Charitable Foundation Research Award in Women’s Health.

A smiling Manali Mukherjee in a lab.

Immunologist Manali Mukherjee receives Falling Walls Women’s Impact Award 

The prestigious international award recognizes Mukherjee’s patient-centred, evidence-based research on Long COVID. 
Two researchers in lab coats and gloves smile as they work on complicated apparatus in the lab with lots of pipes and tubes.

Inside the McMaster lab that is making life-saving medicine more affordable

German life sciences company Sartorius and McMaster are working together to make it cheaper and more efficient to manufacture medications and drive down patient costs.  
Randy Jackson looks up and off to the side while standing outside in an area with trees.

McMaster researcher receives $24M to transform Indigenous sexual health research and care 

Randy Jackson's project, supported by a New Frontiers in Research Fund grant, will address how sexually transmitted and blood-borne infections are researched and addressed in Indigenous communities.